Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2026-04-21 @ 10:40 AM
Study NCT ID:
NCT00933894
Status:
COMPLETED
Last Update Posted:
2010-12-17
First Post:
2009-07-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram
Sponsor:
Tibotec BVBA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CR016303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Compound Development Team Leader
Old Organization:
Tibotec Pharmaceuticals, Ireland